Skip to content

Effect Of Oil Amla Khas And Oil Hina With Drugs Like Shoneez And Mom In Androgenic Alopecia A Randomized Single Blind Controlled Trial

Efficacy of Roghan Amla Khas versus Roghan Hina with Shoneez and Mom In Androgenic Alopecia (Sala) A Randomized Single-Blind Comparative Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080414
Enrollment
34
Registered
2025-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Oil Of Hina with Shoneez and Mom: 10 ml of oil for Local application on the scalp with gentle massage daily twice a day Intervention2: Roghan Hina with Shoneez and Mom: 10 ml of oil f

Sponsors

National Institute Of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Known Cases Of Androgenic Alopecia In Male Subject With Age 20-50 Years 2.Subjects With Grade I to IV AGA According To The Modified Norwood-Hamilton Scale

Exclusion criteria

Exclusion criteria: 1.Subjects having diseases like scalp psoriasis, tinea capitis, Lichen Planopilaris, Trichotillomania, scarring alopecia, and alopecia areata 2.Subjects with history of CAM (complementary and alternative medicine) therapy or anti-androgenic medications or drugs causing hypertrichosis (phenytoin, acetazolamide, cyclosporine, diazoxide, psoralens, penicillamine, streptomycin and cortisone) or hypotrichosis (anti-coagulants, retinoids, lithium and beta blockers), use of finasteride or other 5-a reductase inhibitors or topical minoxidil within 01 month prior to enrolment 3.Subject with History of hair transplantation.

Design outcomes

Primary

MeasureTime frame
Change in Trichoscopy Features (Hair shaft thickness heterogeneity, peripilar sign, follicular unit with single hair and yellow dots)Timepoint: 0th Day,15th Day,30th Day,45th Day,60th Day

Secondary

MeasureTime frame
Decrement in score of Patient Self Assessment Questionnaire Investigator Assessment Using Photography Decrement In score of Hair Specific Skindex-29 Timepoint: 0th Day,15th Day,30th Day, 45th Day,60th Day

Countries

India

Contacts

Public ContactProf mohd Aleemuddin Quamri

National Institute Of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026